Positive Data for Cannabis Chewing Gum to be Used in Upcoming IBS Trial

Article

CanChew Plus CBD Gum to be tested in irritable bowel syndrome clinical trial.

AXIM Biotechnologies, Inc received positive pharmacokinetic (PK) data results for its CanChew Plus cannabidiol (CBD) Gum, according to a company press release.

CanChew Plus is a non-habit forming, hemp-derived CBD functional chewing gum that is available in all 50 states. Currently, AXIM is gearing up for a clinical trial to prove the efficacy of CBD for the treatment of irritable bowel syndrome (IBS).

The single-dose study for 10 mg and 30 mg of CBD determined the concentration of CBD in the blood after chewing CanChew Plus Gum for 30 minutes in healthy participants.

The results of the study showed the 30 mg dosage as the most favorable, and the data will be used to determine the optimal dosage for patients in the IBS trial, according to the release.

“These results show that excellent bioavailability for CBD may be achieved via our proprietary chewing gum delivery system, so that patients suffering from IBS may have symptomatic relief using an easy-to-use solution,” said George E. Anastassov, MD, DDS, MBA, chief executive officer of AXIM Biotech. “We believe that we can match or improve the bioavailability profile for CBD compared to other delivery systems such as smoking or oral intake. We look forward to entering clinical trial and making available our cannabis-based medicinal solutions to patients suffering from IBS and other gastrointestinal disorders as soon as possible.”

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.